Compare LUV & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | WAT |
|---|---|---|
| Founded | 1967 | 1958 |
| Country | United States | United States |
| Employees | N/A | 7600 |
| Industry | Air Freight/Delivery Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 23.5B |
| IPO Year | N/A | 1995 |
| Metric | LUV | WAT |
|---|---|---|
| Price | $37.87 | $394.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $34.31 | ★ $382.14 |
| AVG Volume (30 Days) | ★ 7.3M | 531.7K |
| Earning Date | 10-22-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 3.82 |
| EPS | 0.67 | ★ 10.88 |
| Revenue | ★ $27,551,000,000.00 | $3,105,638,000.00 |
| Revenue This Year | $3.65 | $7.96 |
| Revenue Next Year | $7.79 | $6.32 |
| P/E Ratio | $56.92 | ★ $36.30 |
| Revenue Growth | 0.64 | ★ 6.90 |
| 52 Week Low | $23.82 | $275.05 |
| 52 Week High | $38.17 | $423.56 |
| Indicator | LUV | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 74.23 | 61.33 |
| Support Level | $35.12 | $386.09 |
| Resistance Level | $35.39 | $403.80 |
| Average True Range (ATR) | 1.23 | 9.63 |
| MACD | 0.45 | -1.66 |
| Stochastic Oscillator | 95.72 | 53.55 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In late 2025, Southwest will modify its cabins to offer some rows with extra legroom and will update its ticketing process and merchandising to offer assigned seats and more fare categories, including a basic economy class that will more directly compete with other airlines' offerings and appear for the first time in travel aggregators' search results.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.